Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Perazella

Showing results (31-40 of 278) with videos related to

Pageof 28
Sort By:
Advances in Chronic Kidney Disease|March 13, 2017
Clinical Approach to Diagnosing Acute and Chronic Tubulointerstitial DiseaseMark A Perazella
Kidney360|October 17, 2022
Vancomycin Should Be Considered a Nephrotoxic Antimicrobial Agent: COMMENTARYMark A Perazella
Seminars in Dialysis|January 30, 2008
Tissue deposition of gadolinium and development of NSF: a convergence of factorsMark A Perazella
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 1, 2010
Toxic nephropathies: core curriculum 2010Mark A Perazella
JAMA|May 16, 2019
Acute Kidney Injury Related to SepsisMark A Perazella
Jornal Brasileiro De Nefrologia|March 5, 2020
Is urine microscopy a useful early biomarker for cardiac surgeryrelated AKI?Mark A Perazella
Clinical Journal of the American Society of Nephrology : CJASN|April 7, 2018
Pharmacology behind Common Drug NephrotoxicitiesMark A Perazella
Seminars in Dialysis|May 20, 2003
Nephrogenic fibrosing dermopathy: an unusual skin condition associated with kidney diseaseMark A Perazella, Shuta Ishibe, Mark A Perazella, et al.
Seminars in Dialysis|August 9, 2006
Nonhematologic complications of erythropoietin therapyXiaolei Zhu, Mark A Perazella
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 25, 2017
Adverse kidney effects of epidermal growth factor receptor inhibitorsHassan Izzedine, Mark A Perazella
Pageof 28

Showing results (31-40 of 278) with videos related to

Sort By:
Pageof 28
Advances in Chronic Kidney Disease|March 13, 2017
Clinical Approach to Diagnosing Acute and Chronic Tubulointerstitial DiseaseMark A Perazella
Kidney360|October 17, 2022
Vancomycin Should Be Considered a Nephrotoxic Antimicrobial Agent: COMMENTARYMark A Perazella
Seminars in Dialysis|January 30, 2008
Tissue deposition of gadolinium and development of NSF: a convergence of factorsMark A Perazella
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 1, 2010
Toxic nephropathies: core curriculum 2010Mark A Perazella
JAMA|May 16, 2019
Acute Kidney Injury Related to SepsisMark A Perazella
Jornal Brasileiro De Nefrologia|March 5, 2020
Is urine microscopy a useful early biomarker for cardiac surgeryrelated AKI?Mark A Perazella
Clinical Journal of the American Society of Nephrology : CJASN|April 7, 2018
Pharmacology behind Common Drug NephrotoxicitiesMark A Perazella
Seminars in Dialysis|May 20, 2003
Nephrogenic fibrosing dermopathy: an unusual skin condition associated with kidney diseaseMark A Perazella, Shuta Ishibe, Mark A Perazella, et al.
Seminars in Dialysis|August 9, 2006
Nonhematologic complications of erythropoietin therapyXiaolei Zhu, Mark A Perazella
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 25, 2017
Adverse kidney effects of epidermal growth factor receptor inhibitorsHassan Izzedine, Mark A Perazella
Pageof 28